A regulatory navigator for organizations exposed to COVID reinfection. The practice spans school districts, hospital systems, insurers, and legislative offices, anchored by the COVID Mitigation ROI Economic Model delivered to Senate HELP Committee advisors on March 15, 2026.
01 / Regulatory Navigator
MP Consulting operates as a regulatory navigator for school districts, hospital systems, insurers, and legislative offices. The COVID reinfection landscape is moving fast and asymmetrically. Clients need a counterpart who reads the rule changes early, translates them into operational decisions, and represents the organization's interests while agencies are still drafting the standard.
The practice rests on four core functions, each anchored by the auditable methodology behind the COVID Mitigation ROI Economic Model.
A line by line review of an organization's mitigation posture, indoor air practices, and Long COVID accommodation framework against current ASHRAE Standard 241 guidance, OSHA expectations, and emerging federal indoor air strategy. The output is a clear map of exposure points and the shortest paths to closure.
State IAQ legislation. FDA pathway changes. Federal HHS reorganization. ADA precedent on Long COVID. ASHRAE adoption cycles. MP Consulting watches the horizon so clients adapt months or years ahead of peers, not after enforcement arrives.
For ventilation retrofits, mitigation policy adoption, or program and product launch in the IAQ and public health space, MP Consulting identifies the fastest and least risky regulatory pathway, including alignment with federal funding streams across IRA, IIJA, HHS, and state programs.
How does the organization perform if a Long COVID ADA complaint lands? If a building is named in an outbreak investigation? If insurance claims escalate? MP Consulting builds the stress test before the investigation does, in partnership with legal and operations leadership.
Effective regulatory navigation is collaborative, not adversarial. MP Consulting brings legislative office relationships and OECD aligned methodology to client work. Early engagement with agency personnel during program design clarifies expectations and shortens approval cycles. The work is built on relationships already in motion: Senate HELP Committee advisors, the Sanders health policy office, and international research partners.
02 / About
Marty Pack is a policy analyst, researcher, and creative producer with field experience that began in public health investigation and now sits at the intersection of federal policy, economic modeling, and documentary advocacy. Her focus, since August 2020, has been a topic most institutions still flinch from naming clearly: COVID reinfection.
Through MP Consulting, Marty advises school districts, hospital systems, insurers, and legislative offices on the fiscal and human costs of unmitigated transmission. Through Wail of a Tale Productions, the 501(c)(3) nonprofit she founded in 2021, she produces documentary work designed from pre production forward to generate legislative evidence infrastructure.
The result is a practitioner who can speak with equal precision to a Senate health adviser, a hospital CFO, a producer at a national podcast, or a parent asking why their child is sick again.
03 / The Model
Marty Pack created the COVID Mitigation ROI Economic Model: a benefit cost framework that quantifies the federal fiscal and social welfare returns of investing in proven COVID mitigation. It is OMB Circular A-94 compliant and draws on 112 peer reviewed sources.
Delivered to Senate HELP Committee advisors on March 15, 2026, Long COVID Awareness Day. Methodology aligned with and verified through OECD's framework, April 2026. Active engagement with the Sanders health team.
The COVID Mitigation ROI Economic Model is the canonical title. The model is filed with the U.S. Copyright Office under that name.
04 / Validation
In April 2026, the OECD published Addressing the Costs and Care for Long COVID, a microsimulation across 42 countries. The methodology behind the COVID Mitigation ROI Economic Model is aligned with and verified through the OECD's framework. The shared architecture, dual frame valuation and the dominance of indirect over direct costs, is identical.
The OECD framework provides international validation. OECD's reach across 42 countries comes at the cost of U.S. specific cost lines: U.S. cohort data on reinfection compounding, U.S. peer reviewed literature on downstream noncommunicable disease burden, and the OMB Circular A-94 standard required for U.S. appropriations decisions. The COVID Mitigation ROI Economic Model carries the cost lines OECD's framework leaves on the table, and provides the U.S. federal instrument.
OECD does not model reinfection. The COVID Mitigation ROI Economic Model prices it, anchored in the Statistics Canada cohort showing 15 percent Long COVID risk after one infection, 27 percent after two, 38 percent after three. The Barcelona cohort confirms.
OECD acknowledges cardiovascular, diabetes, and noncommunicable disease acceleration in narrative, then excludes them from the cost model. The COVID Mitigation ROI Economic Model carries them through, priced via downstream healthcare and disability cost lines.
Excess mortality from cardiovascular and cerebrovascular sequelae is unmonetized in OECD. The COVID Mitigation ROI Economic Model reflects it directly in benefit lines.
OECD is descriptive across 42 countries. The COVID Mitigation ROI Economic Model is OMB Circular A-94 compliant, the standard required for federal regulatory and appropriations decisions in the United States.
OECD truncates to 2025 through 2035 with assumed recovery. The COVID Mitigation ROI Economic Model carries longer horizon NCD costs that emerge after the OECD model has retired the case.
"No one was looking at reinfection or the cumulative damage COVID is doing to our bodies. Every mitigation effort is a return on investment. No one was doing the work, so I did it."
Marty Pack, M.A. Exec MPA
05 / Speaking
Marty speaks fluently on the science, the economics, and the politics. Each topic is built on auditable data and lived practice.
Why the unwillingness to name reinfection in policy is itself the largest fiscal liability on the table, and what the numbers actually show.
A walk through the COVID Mitigation ROI Economic Model in language a policy adviser, a journalist, or a parent can act on.
Indoor air quality is no longer fringe. What a federal indoor air strategy looks like in practice, and what is blocking it.
What the FY2027 HHS budget tells you about the trajectory of American public health, and where the leverage points still are.
06 / Engagements
The COVID Mitigation ROI Economic Model was delivered to Senate HELP Committee advisors on Long COVID Awareness Day. Engagement with the Sanders health team has continued since.
The model methodology was independently aligned with and verified through OECD's framework (doi:10.1787/87a0c171-en).
Marty Pack met with the health policy liaison to Senator Bernie Sanders on the Senate HELP Committee to walk through the COVID Mitigation ROI Economic Model and its implications for federal investment in mitigation. The engagement is ongoing.
Marty Pack created a Maryland companion model for client MIAQA, led by Adam Van Bavel, returning a 23.4:1 gross social welfare benefit cost ratio at the state level.
"Breathing Lessons: The Science of Safer Schools" (school IAQ, ASHRAE 241, Long COVID in children) and "Cutting Costs / Cutting Lives" (HHS dismantlement, Long COVID, public health infrastructure) are both in active production.
07 / Booking
Available for podcast appearances, regulatory consulting, expert briefings, and on the record interviews. Topics span the COVID Mitigation ROI Economic Model, indoor air quality policy, public health infrastructure, and the documentary as policy advocacy.
For media or consulting inquiries, please use the contact details to the right. A one pager and the OECD comparison brief are available on request.